BioSpace News Archive

Deals

Bristol-Myers Squibb Provides 2019 EPS Guidance

Bristol-Myers Squibb Company today announced EPS guidance for full-year 2019.

January 3, 2019
·
13 min read
Business

StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Officer

Experienced Biotech Executive to Lead Company’s Next Stage of Growth

January 3, 2019
·
3 min read
Genetown

Sojournix Completes $44 Million Series C Financing

Sojournix announced today the completion of a $44 million Series C financing.

January 3, 2019
·
5 min read
Deals

Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company

Highly Complementary Portfolios with Leading Franchises in Oncology, Immunology and Inflammation and Cardiovascular Disease

January 3, 2019
·
21 min read
Business

Nuvo Pharmaceuticals Announces Appointment of Rob Harris as Executive Chairman

Nuvo Pharmaceuticals Inc. today announced the appointment of Rob Harris as its Executive Chairman.

January 3, 2019
·
6 min read
Dompé announces first treatment with Oxervate™ eye drops (cenegermin-bkbj), for neurotrophic keratitis (NK)

Now available through Accredo, Oxervate is the first-in-class recombinant human nerve growth factor (rhNGF) and holds the potential to completely heal NK.

January 3, 2019
·
8 min read
Business

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel

Analytics 4 Life today announced that it has further strengthened its leadership team with the appointment of William Revelos as Vice President and General Counsel.

January 3, 2019
·
2 min read
Business

1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma

1ST Biotherapeutics, Inc. and twoXAR, Inc. today announced an agreement to jointly discover and develop novel, efficacious treatments to address unmet medical needs in glioblastoma multiforme (“glioblastoma”).

January 3, 2019
·
3 min read
Pharm Country

Provention Bio Announces Publication in “Expert Review of Vaccines” Describing the Scientific Rationale for Developing a Vaccine for Type 1 Diabetes by Targeting Coxsackievirus B

Provention is currently developing PRV-101 as a vaccine for acute coxsackie infection and to potentially prevent the onset of T1D

January 3, 2019
·
4 min read
Business

Surgical Affiliates Announces Partnership with McLaren Oakland Hospital to Enhance and Expand Emergency Surgical Services

Surgical Affiliates announces its partnership with McLaren Oakland Hospital in Pontiac, MI, today.

January 3, 2019
·
3 min read